Company Filing History:
Years Active: 1999
Title: Michael Joseph Thurn: Innovator in Cancer Treatment
Introduction
Michael Joseph Thurn is an accomplished inventor based in New South Wales, Australia. He has made significant contributions to the field of cancer treatment through his innovative research and development. His work focuses on utilizing legume plant extracts for therapeutic purposes.
Latest Patents
Thurn holds a patent for "Methods for treating cancer with legume plant extracts." This invention relates to the preparation of therapeutic compositions that comprise extracts of leguminous plants. The patent specifically addresses the removal of isoflavones such as genistein, daidzein, formononetin, and biochanin, along with their glycosides. The therapeutic uses of these extracts are aimed at treating, preventing, and ameliorating various types of cancers.
Career Highlights
Thurn is associated with Novogen Limited, a company known for its focus on developing innovative cancer therapies. His work at Novogen has been instrumental in advancing research in the field of oncology. With a patent portfolio that includes 1 patent, he continues to contribute to the scientific community.
Collaborations
Thurn collaborates with Li Jiu Huang, a fellow researcher, to further explore the potential of legume plant extracts in cancer treatment. Their combined efforts aim to enhance the efficacy of therapeutic compositions derived from these natural sources.
Conclusion
Michael Joseph Thurn's innovative work in cancer treatment exemplifies the potential of natural extracts in modern medicine. His contributions through patents and collaborations continue to pave the way for advancements in oncology.